Histotripsy does more than mechanically break down tumours. When tumour cells are fragmented, they release cellular debris ...

Molecular and genetic testing has become a game-changer in brain tumor care—shaping diagnosis, guiding treatments and opening doors to new therapies. Once available to a handful of patients, these ...

The MHRA has approved tisotumab vedotin for adults with recurrent or metastatic cervical cancer, offering a new option after ...

Researchers focused on accelerating and testing new treatments for low-grade brain tumors are set to receive a transformative £2.8 million to drive their future work.

Radiation therapy treatment for breast cancer not only improves survival rates but also generates long-term financial benefits, according to a new study from the University of Copenhagen. Survivors of ...

Gynecologic cancer research is exploring new protocols with Abraxane, relacorilant, and Avastin, including trials in platinum-sensitive and endometrial cancer populations. Breast cancer advancements ...

Biomedical research typically follows a familiar path: developing treatments that block, enhance or mutate certain signaling pathways, genes or proteins to change the function of different cells in ...

The landscape of oncology is undergoing a transformative shift with the emergence of tumor-agnostic approaches, driven by the understanding that cancer treatment can transcend the traditional paradigm ...

A pioneering low-energy X-ray treatment for a specific type of cancer has received approval for use within the NHS, ...

A glioblastoma (GBM) clinical trial led by Dr. Danielle Bazer, DO, neuro-oncologist and Lead for Neuro-Oncology at MD Anderson Cancer Center at Cooper University, is leveraging IB's Functional Tumor ...

The technology may be particularly valuable for monitoring MGMT methylated tumors, which typically show better response to temozolomide treatment. Michael Schmainda, CEO of Imaging Biometrics, ...